TY - JOUR
T1 - Cumulative Small Effect Genetic Markers and the Risk of Colorectal Cancer in Poland, Estonia, Lithuania, and Latvia
AU - Serrano-Fernandez, Pablo
AU - Dymerska, Dagmara
AU - Kurzawski, Grzegorz
AU - Derkacz, Róza
AU - Sobieszczańska, Tatiana
AU - Banaszkiewicz, Zbigniew
AU - Roomere, Hanno
AU - Oitmaa, Eneli
AU - Metspalu, Andres
AU - Janavičius, Ramunas
AU - Elsakov, Pavel
AU - Razumas, Mindaugas
AU - Petrulis, Kestutis
AU - Irmejs, Arvids
AU - Miklaševičs, Edvins
AU - Scott, Rodney J.
AU - Lubiński, Jan
N1 - Publisher Copyright:
© 2015 Pablo Serrano-Fernandez et al.
PY - 2015
Y1 - 2015
N2 - The continued identification of new low-penetrance genetic variants for colorectal cancer (CRC) raises the question of their potential cumulative effect among compound carriers. We focused on 6 SNPs (rs380284, rs4464148, rs4779584, rs4939827, rs6983267, and rs10795668), already described as risk markers, and tested their possible independent and combined contribution to CRC predisposition. Material and Methods. DNA was collected and genotyped from 2330 unselected consecutive CRC cases and controls from Estonia (166 cases and controls), Latvia (81 cases and controls), Lithuania (123 cases and controls), and Poland (795 cases and controls). Results. Beyond individual effects, the analysis revealed statistically significant linear cumulative effects for these 6 markers for all samples except of the Latvian one (corrected P value = 0.018 for the Estonian, corrected P value = 0.0034 for the Lithuanian, and corrected P value = 0.0076 for the Polish sample). Conclusions. The significant linear cumulative effects demonstrated here support the idea of using sets of low-risk markers for delimiting new groups with high-risk of CRC in clinical practice that are not carriers of the usual CRC high-risk markers.
AB - The continued identification of new low-penetrance genetic variants for colorectal cancer (CRC) raises the question of their potential cumulative effect among compound carriers. We focused on 6 SNPs (rs380284, rs4464148, rs4779584, rs4939827, rs6983267, and rs10795668), already described as risk markers, and tested their possible independent and combined contribution to CRC predisposition. Material and Methods. DNA was collected and genotyped from 2330 unselected consecutive CRC cases and controls from Estonia (166 cases and controls), Latvia (81 cases and controls), Lithuania (123 cases and controls), and Poland (795 cases and controls). Results. Beyond individual effects, the analysis revealed statistically significant linear cumulative effects for these 6 markers for all samples except of the Latvian one (corrected P value = 0.018 for the Estonian, corrected P value = 0.0034 for the Lithuanian, and corrected P value = 0.0076 for the Polish sample). Conclusions. The significant linear cumulative effects demonstrated here support the idea of using sets of low-risk markers for delimiting new groups with high-risk of CRC in clinical practice that are not carriers of the usual CRC high-risk markers.
KW - Medicine
UR - http://www.scopus.com/inward/record.url?scp=84935836599&partnerID=8YFLogxK
U2 - 10.1155/2015/204089
DO - 10.1155/2015/204089
M3 - Article
AN - SCOPUS:84935836599
SN - 1687-6121
VL - 2015
JO - Gastroenterology Research and Practice
JF - Gastroenterology Research and Practice
M1 - 204089
ER -
